JMJosef Marksteiner

Josef Marksteiner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josef Marksteiner has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Zusammenhang zwischen Mild Cognitive Impairment (MCI) und Depression

    by Michaela Defrancesco, Josef Marksteiner, E. A. Deisenhammer, Hartmann Hinterhuber, Elisabeth M. Weiss


    • 1 January 2010
      • Vol. 24  (2) , 88-98

    [Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].

    by Michaela Defranceso, Michael Schocke, Hubert J Messner, Eberhard A Deisenhammer, Hartmann Hinterhuber, Josef Marksteiner, Elisabeth M Weiss

    The first part of this article deals with the concept of Mild Cognitive Impairment and its role in the pathogenesis of dementia. In the second part neuroradiologic diagnostic methods which can potentially help to predict the conversion of MCI to Alzheimer s disease (DAT) are discussed. We reviewed in PubMed published literature for reports which investigated diagnosis and progress of patients with MCI and DAT. Patients with MCI older than 65 years have a risk of 10-15%/year to develop dementia in comparison to the healthy population with a risk of 2%/year. Neuroradiologic methods such as MR-spectroscopy, FDGPET, DWI and VBM are able to differentiate patients who will convert to DAT from patients who remain stable. Structural changes can be detected prior to clinically measurable cognitive deficits. The neuroradiologic examination using MR- Spectroscopy, VBM, DWI or FDG-PET show early structural and functional changes which can predict a conversion from MCI to DAT.


  • Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment

    by Tanja Hochstrasser, Elisabeth Weiss, Josef Marksteiner, Christian Humpel


    • 1 January 2009
      • Vol. 23  (1) , 4-14

    [Dementia and music].

    by Manuela Kerer, Josef Marksteiner, Hartmann Hinterhuber, Guerino Mazzola, Reinhard Steinberg, Elisabeth M Weiss

    Patients suffering from dementia are nevertheless still able to render exceptional musical performances. For example, they can recognize music from childhood and reproduce lyrics and melodies of songs with four verses. Furthermore, behavioural symptoms such as psycho- motor agitation and crying, but also aggressive behaviour can be positively influenced by music and motivation and positive emotions can be increased. A variety of physiological and psychological changes occur when patients are listening to music. Previous research could show that music activated different parts of the brain especially in the temporal cortex, but also motoric areas in the frontal cortex, thalamus and cerebellum were essential for rhythm, melody and harmony perception and processing. Music therapy is an interpersonal process in which music is used within a therapeutic relationship to address physical, emotional, cognitive, and social needs of individuals with various psychiatric or medical conditions. However, until now only little research has been directed towards non-pharmacological treatments like music therapy in dementia patients. Further research is warranted to investigate the long term influence of music therapy on patients suffering from dementia.


    • 1 January 2009
      • Vol. 23  (3) , 144-50

    [Association of Mild Cognitive Impairment (MCI) and depression].

    by Michaela DeFrancesco, Josef Marksteiner, E A Deisenhammer, Hartmann Hinterhuber, Elisabeth M Weiss

    Mild Cognitive Impairment is a heterogeneous entity. Incidence and prevalence of MCI are highly dependent on the diagnostic criteria applied. Geriatric depression is more frequently associated with cognitive deficits and somatic complaints than depression in younger age. Consequently, depressive symptoms in the elderly are often misinterpreted and not treated adequately. The aim of this review is to point out possible explanations for the high incidence of depression in patients with MCI and to compare prior studies who worked on this interrelation. We review the existing literature on the relationship between MCI and depression. There is no consensus on the question whether depression is the consequence or the cause for cognitive impairment in older people. The comparability of prior studies which dealt with the relationship between depression and MCI is limited due to the use of different diagnostic criteria and depression scales. It can be concluded that there is an association between MCI and depression which leads to a worse clinical outcome of depression and maybe a faster progression of cognitive decline.


  • Geschlechtsspezifische Unterschiede der Alzheimer Demenz

    by Reinhold Schmidt, Eva Assem-Hilger, Thomas Benke, Peter Dal-Bianco, Margarete Delazer, Gunther Ladurner, Kurt Jellinger, Josef Marksteiner, Gerhard Ransmayr, Helena Schmidt, et al.

  • Diagnostik der Alzheimer Demenz und anderer Demenzen in der Cerebrospinalfl

    by Christian Humpel, Imrich Blasko, Josef Marksteiner, Wolfgang Lederer, Harald Oberbauer, Thomas Walch, Georg Kemmler, Hartmann Hinterhuber

  • Chromogranin B and Secretogranin II in Transgenic Mice Overexpressing Human APP751 with the London (V717I) and Swedish (K670M/N671L) Mutations and in Alzheimer Patients

    by Michael Willis, Manuela Prokesch, Birgit Hutter-Paier, Manfred Windisch, Mats Stridsberg, Sushil K. Mahata, Rudolf Kirchmair, Georg Wietzorrek, Hans-Günther Knaus, Kurt Jellinger, et al.

    Chromogranin B and secretogranin II are major soluble constituents of large dense core vesicles of presynaptic structures and have been found in neuritic plaques of Alzheimer patients. We examined the distribution and expression of these peptides in


    • 1 January 2008
      • Vol. 22  (1) , 1-15

    [Sex differences in Alzheimer's disease].

    by Reinhold Schmidt, Eva Kienbacher, Thomas Benke, Peter Dal-Bianco, Margarete Delazer, Gunther Ladurner, Kurt Jellinger, Josef Marksteiner, Gerhard Ransmayr, Helena Schmidt, et al.

    The prevalence of Alzheimer disease is higher in women than in men. In the age group 65-69 years 0.7% of women and 0.6% of men suffer from the disease with increasing frequencies of 14.2% and 8.8% in individuals aged 85-89 years. The incidence is also higher in demented women. In Austria 74.1% of Alzheimer patients older than 60 years are women. Several studies report more pronounced language, mnestic, semantic and orientation deficits in women, but methodological shortcomings might be responsible for this finding. The validity of results reporting a more rapid cognitive decline in women can also be questioned. Women have a broader spectrum of dementiarelated behavioural symptoms with a predominance of depression, while aggression is more frequent in men than in women. Biological explanations for gender-specific differences in the phenotype of Alzheimer s disease include different brain morphology and function with higher susceptibility for pathological lesions in women and greater cognitive reserve in men. Sex differences were also reported for expression of antioxidative enzymes and post-menopausal hormonal changes. Interactions between gender nd response to treatment, if any, are subtle and have large intra-individual variability. In Austria, two thirds of patients receiving attendance allowance are women. Care takes place in 80% by the families and is provided by women in 78%. The rate of female care-givers in partly institutionalized care units in 91% in nursing homes it is 84%.